Skip to main content
Clinical Trials/NCT02170051
NCT02170051
Completed
N/A

Improving Negative Symptoms of Psychosis In Real-world Environments

University of California, San Diego1 site in 1 country64 target enrollmentJuly 1, 2014
ConditionsSchizophrenia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
University of California, San Diego
Enrollment
64
Locations
1
Primary Endpoint
Clinical Assessment Interview for Negative Symptoms (CAINS)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study will compare Cognitive Behavioral Social Skills Training-Compensatory Cognitive Training (CBSST-CCT) to a goal-focused supportive contact group to see which intervention better improves symptoms and functioning in people with schizophrenia.

Registry
clinicaltrials.gov
Start Date
July 1, 2014
End Date
September 3, 2018
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elizabeth Twamley

Professor of Psychiatry

University of California, San Diego

Eligibility Criteria

Inclusion Criteria

  • MUST BE A RESIDENT OF BROADWAY HOME, SAN DIEGO, OR A SERVICE USER OF THE MEETING PLACE, ARETA CROWELL, OR PROJECT ENABLE.
  • Voluntary informed consent to participate
  • Age 18 to 65
  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder based on MINI/SCID
  • Moderate-to-severe negative symptoms on the Clinical Assessment Interview for Negative Symptoms (CAINS total score \>19)
  • ≥ 6th grade reading level on the Wide Range Achievement Test-4 Reading subtest (needed for reading treatment manual)
  • Stable on medications; no changes within 3 months prior to enrollment

Exclusion Criteria

  • Prior CBT, SST, or CCT in the past 5 years
  • Severe positive symptoms on the Positive and Negative Syndrome Scale (PANSS Delusions, Disorganization, Hallucinations, or Suspiciousness \>5)
  • Severe depression on the Calgary Depression Scale for Schizophrenia (CDSS \>8)
  • Ocular damage/disease/surgery/medications that affect pupil dilation
  • DSM-IV alcohol or substance dependence diagnosis in past 6 months based on the MINI or SCID
  • Level of care required interferes with outpatient therapy (e.g., hospitalized; severe medical illness) .

Outcomes

Primary Outcomes

Clinical Assessment Interview for Negative Symptoms (CAINS)

Time Frame: baseline, 12.5 weeks

Change in negative symptom severity at 12.5 weeks. Scores range from 0-52; higher values indicate greater severity.

Secondary Outcomes

  • MATRICS Consensus Cognitive Battery (MCCB)(baseline, 12.5 weeks)
  • UCSD Performance-based Skills Assessment-Brief (UPSA-B)(baseline, 12.5 weeks)
  • Social Skills Performance Assessment (SSPA)(baseline, 12.5 weeks)
  • Specific Levels of Functioning Scale (SLOF)(baseline, 12.5 weeks)
  • Independent Living Skills Survey (ILSS)(baseline, 12.5 weeks)
  • Defeatist Performance Attitudes Scale (DPAS)(baseline, 12.5 weeks)
  • Scale for the Assessment of Negative Symptoms (SANS)(baseline, 12.5 weeks)

Study Sites (1)

Loading locations...

Similar Trials